Answers are grounded in this paper and cite their sources.
Editorial review examines the mechanisms of proteostasis in cardiomyocytes, indicating that protein quality control failure drives heart failure.
Editorial on the Research Topic Proteostasis in cardiac health and diseaseCardiovascular diseases (CVDs) are the leading cause of death worldwide.The past few decades saw witness to exhilarating efforts from researchers across the globe to uncover the underlying molecular mechanisms of CVDs.Only recently, however, has protein homeostasis or proteostasis as a key cellular process caught attention in the context of heart failure and cardiomyopathy (Wang and Robbins, 2006).Proteostasis involves complex and tightly regulated processes to balance the production, folding, trafficking, and degradation of cellular proteins (Henning and Brundel, 2017).Protein synthesis and folding are monitored by a specialized system, collectively called Protein Quality Control (PQC), where chaperones, the Ubiquitin-Proteasome System (UPS), and sometimes autophagy act as central players.PQC impairment or inadequacy may result in aberrant protein aggregation which in turn impairs the UPS and further increases proteotoxic stress, which may eventually lead to cell death (Wang and Wang, 2020).Due to the exceptionally high mechanical, thermal, and oxidative stresses in working cardiomyocytes, maintaining their proteostasis is particularly challenging but crucial for the health and function of these cells and the heart (Henning and Brundel, 2017).Accumulation of misfolded proteins and aberrant protein aggregation are now even considered a hallmark of a large subset of cardiac diseases (Sanbe et al., 2004;Hofmann et al., 2019;Wang and Wang, 2020).However, we are still far from understanding the exact mechanisms regulating cardiac proteostasis.The aim of the articles in this Research Topic is to shed light on the still undiscovered aspects of proteostasis in the heart and its role in cardiac health and disease.Of particular interest hereby is the UPS.UPS-mediated proteolysis is the primary degradation system to remove aberrant proteins.Alterations of the UPS have been reported in several human and experimental cardiac disorders (Mearini et al., 2008;Schlossarek et al., 2014).Consistent with this, Trogisch et al. investigate whether lack of LMP2, an immune or inducible subunit of the 20S proteasome, and thereby reduced proteasome plasticity, impact cardiac remodeling and function under chronic β-adrenergic stimulation, a major contributor to the development of heart failure.While cardiac function of LMP2 constitutive knock-out (KO) mice remained unchanged under unchallenged conditions, continuous β-adrenergic
No takes yet. Share an insight, caveat, or question.
Bühringer et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: